Merakris Announces Nationwide At-Your-Door Autologous Serum Tears Program
12 oct. 2023 06h30 HE
|
Merakris Therapeutics
The Opticyte Tears program uses patients’ blood serum to create Autologous Serum Tears from the convenience of their homes.
NTC and I-MED Pharma form strategic partnership to bring the leading HA-based dry eye ointment to the United States market
15 déc. 2021 07h00 HE
|
I-MED Pharma
MONTREAL, Dec. 15, 2021 (GLOBE NEWSWIRE) -- NTC Srl, R&D driven pharmaceutical company with headquarters in Italy, and I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and...
I-MED Pharma USA Announces Michelle Schnabel as VP Business Development
09 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 09, 2021 (GLOBE NEWSWIRE) -- With the recent expansion into the United States, I-MED Pharma USA is proud to announce the appointment of Michelle Schnabel to the role of VP Business...
I-MED Pharma Set to Launch Its Innovative Dry Eye Product Portfolio in the U.S.A.
05 nov. 2021 11h00 HE
|
I-MED Pharma
MONTREAL, Nov. 05, 2021 (GLOBE NEWSWIRE) -- I-MED Pharma USA is bringing the world’s most innovative dry eye product portfolio to the U.S. market. Their uniquely formulated line of ocular surface...
I-MED Pharma launches tearcheck® in Canada - A new standard in dry eye analysis
10 nov. 2020 10h20 HE
|
I-MED Pharma
MONTREAL, Nov. 10, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announces the launch of tearcheck®, a new Health Canada approved...
I-MED Pharma to Launch Its Most Advanced Artificial Tear to Date With I-DROP® MGD
03 févr. 2020 14h11 HE
|
I-MED Pharma
MONTREAL, Feb. 03, 2020 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, announced today that the company has plans to launch its newest,...
I-MED Pharma Partners with Simovision to Bring the I-PEN® Osmolarity System to Belgium, Luxembourg & the Netherlands
02 oct. 2018 10h54 HE
|
I-MED Pharma
MONTREAL, Oct. 02, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma Inc. Announces Partnership with Medicals International
23 juil. 2018 11h41 HE
|
I-MED Pharma
MONTREAL, July 23, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of an exclusive agreement with...
I-MED Pharma présente la technologie éprouvée E>Eye IRPL® au Canada
24 mai 2018 13h36 HE
|
I-MED Pharma
MONTRÉAL, 24 mai 2018 (GLOBE NEWSWIRE) -- I-MED Pharma inc., une entreprise canadienne spécialisée dans le diagnostic et la prise en charge de la sécheresse oculaire, est ravie d’annoncer...
I-MED Pharma to Bring Clinically Proven E>Eye IRPL® Technology to Canada
24 mai 2018 13h36 HE
|
I-MED Pharma
MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- I-MED Pharma Inc., a Canadian company specializing in dry eye diagnosis and management, is pleased to announce the signing of a Canadian distribution...